Facilitated Transition to Primary Care for Postpartum

N/A

Waitlist Available

Led By Mark A Clapp, MD, MPH

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have anxiety, depression, chronic hypertension, pregnancy-related hypertensive disorder, pre-pregnancy diabetes, gestational diabetes, or pre-pregnancy Class 2 obesity documented in the current 'problem list,' medical history, or clinical notes that appear in their electronic health record

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 122 days after delivery

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve postpartum primary care for new mothers by implementing a multi-component intervention during inpatient postpartum care. The goal is to increase primary care engagement, quality, and experience

Who is the study for?

This trial is for postpartum individuals with chronic conditions such as high blood pressure, diabetes, depression, anxiety, or obesity. It aims to help those who have just given birth and are at risk of or already dealing with these health issues.

What is being tested?

The study tests a new way to improve the transition from postpartum care to regular primary care. Participants will receive extra support through a program designed using behavioral economics principles to see if it enhances their engagement and management of chronic conditions.

What are the potential side effects?

Since this intervention focuses on improving healthcare coordination rather than medication or medical procedures, there are no direct side effects associated with typical clinical trials. However, participants may experience changes in their healthcare routine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a history of anxiety, depression, hypertension, diabetes, or obesity noted in my medical records.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 122 days after date of delivery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~122 days after date of delivery

This trial's timeline: 3 weeks for screening, Varies for treatment, and 122 days after date of delivery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Completion of a primary care visit

Patient report of having a known, reliable primary care clinician

Receipt of recommended health screening and counseling by a primary care clinician

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Routine CareActive Control1 Intervention

Routine postpartum care

Group II: Facilitated Transition GroupActive Control1 Intervention

The intervention is integrated into routine inpatient postpartum care and includes the following components: default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.

0 / 1Eligibility criteria met